Hep C Drug Stocks in the Spotlight

Description:

According to Adam Feuerstein, "Biotech and drug investors with interest in emerging treatments for hepatitis C turn their attention this week to the European Association for the Study of the Liver (EASL) annual meeting, which kicks off Weds. March 30." Read more here.

>>Also: Top-Rated Biotech Stocks

>>Also: 40 Stocks Analysts Are Insanely Bullish About

Most Viewed Portfolios

View All

Articles

3 Stocks Rising on Big Volume

07.22.14 | 07:00 AM

DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track...

5 Defense Stocks to Trade for Gains This Week

07.22.14 | 10:20 AM

BALTIMORE (Stockpickr) -- Geopolitical turmoil has been ramping up anxiety in the markets in 2014, with escalating conflicts in Ukraine and the Mid...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter